UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
An entry point for newcomers, outlining which blockchains are simplest to learn, set up wallets, and start using.
19,955 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Palantir has been in the AI spotlight, but its stock has traded volatile. This guide helps you separate hype from fun...
NVIDIA faces a supply bottleneck at its chipmaker that could cap near-term revenue even as AI demand remains strong. ...
A high-stakes dispute between MRED and Zillow has led to tens of thousands of Chicago listings being pulled from Zill...
Eight years, 25 properties, 35 units. This is the real-world story behind deal diaries: cameron philgreen, a Texas in...
Markets react as reports surface that the u.s.-iran deal nears, paired with warnings from a Trump ally about Tehran’s...
PayPal remains a leader in digital payments, but its stock faces volatility as growth slows. This guide helps you dec...
A lot of beaten-down SaaS names have bounced recently. This guide explains how to tell if the rise this beaten-down s...
The idea of a bargain in the cruise sector is enticing, but cheap can be risky. This article breaks down how to judge...
A single year's price move and a wave of AI demand have rewritten the memory market narrative. This article explains ...
In 1999, Mark Cuban reportedly earned more from hedging Yahoo shares with a protective collar than from selling Broad...
When a Netflix doc drops and sparks Emmy chatter, money, strategy, and fame collide. This guide explains what cent’s ...